News

May 25, 2018 - ViaCyte to Present at the American Diabetes Association’s 78th Scientific Sessions Read More

May 16, 2018 - Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting Read More

May 1, 2018 - CalciMedica Names Two Senior Executives to its Board of Directors Read More

April 17, 2018 - ViaCyte Awarded NIH SBIR Grant to Support In Vitro Development of Stem Cell-Derived Functional Human Pancreatic Beta Cells Read More

April 9, 2018 - DalCor Pharmaceuticals Announces Dr. Fouzia Laghrissi-Thode as Chief Executive Officer Read More

April 3, 2018 - Dermavant Expands Pipeline & Strengthens Executive Team with Key Hires Read More

April 2, 2018 - ViaCyte to Present at Alliance for Regenerative Medicine’s 6th Annual Cell & Gene Therapy Investor Day in New York City Read More

April 2, 2018 - DalCor Announces Expansion and Accelerated Enrollment of the dal-GenE Clinical Trial Read More

April 1, 2018 - ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications Read More

January 24, 2018 - Research Collaboration between the San Francisco VA, UCSF and CalciMedica, Inc. to Present Results on CRAC Channel Inhibitors in a Stroke Model at International Conference Read More